Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Borgmann

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Journal of Cellular and Molecular Medicine|March 27, 2015
Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cellsIgor Tsaur, Lukasz Hudak, Jasmina Makarević, et al.
Urologic Oncology|October 1, 2018
Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary updateIgor Tsaur, Isabel Heidegger, Alexander Kretschmer, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2015
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patientsIgor Tsaur, Kristina Thurn, Eva Juengel, et al.
Aktuelle Urologie|May 17, 2022
[Impact of the COVID-19 pandemic on urology residency training programs in Germany]Cem Aksoy, Philipp Reimold, Hendrik Borgmann, et al.
Urologia Internationalis|January 6, 2021
Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in UrologyHendrik Borgmann, Julian P Struck, Angelika Mattigk, et al.
European Urology|September 5, 2018
Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social MediaHendrik Borgmann, Matthew Cooperberg, Declan Murphy, et al.
Urologic Oncology|October 16, 2022
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in GermanyMike Wenzel, Angelika Borkowetz, Verena Lieb, et al.
Vascular Pharmacology|June 13, 2025
Vascular diameter determines sensitivity to soluble guanylate cyclase activation in human mesenteric and renal arteriesLubomir T Lubomirov, Simon Jasinski-Bergner, Kangbo Li, et al.
European Journal of Radiology|January 3, 2019
CT-guided nephrostomy-An expedient tool for complex clinical scenariosMaximilian Peter Brandt, Thomas Lehnert, Theresa Czilwik, et al.
Central European Journal of Urology|June 30, 2026
Digital health engagement among urological patients in four European countries: findings from an international cross-sectional survey by the European Association of Urology Section of Outpatient and Office UrologyJohannes Salem, Juan Jose Menendez-Suarez, Matyas Benyo, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Journal of Cellular and Molecular Medicine|March 27, 2015
Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cellsIgor Tsaur, Lukasz Hudak, Jasmina Makarević, et al.
Urologic Oncology|October 1, 2018
Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary updateIgor Tsaur, Isabel Heidegger, Alexander Kretschmer, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2015
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patientsIgor Tsaur, Kristina Thurn, Eva Juengel, et al.
Aktuelle Urologie|May 17, 2022
[Impact of the COVID-19 pandemic on urology residency training programs in Germany]Cem Aksoy, Philipp Reimold, Hendrik Borgmann, et al.
Urologia Internationalis|January 6, 2021
Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in UrologyHendrik Borgmann, Julian P Struck, Angelika Mattigk, et al.
European Urology|September 5, 2018
Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social MediaHendrik Borgmann, Matthew Cooperberg, Declan Murphy, et al.
Urologic Oncology|October 16, 2022
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in GermanyMike Wenzel, Angelika Borkowetz, Verena Lieb, et al.
Vascular Pharmacology|June 13, 2025
Vascular diameter determines sensitivity to soluble guanylate cyclase activation in human mesenteric and renal arteriesLubomir T Lubomirov, Simon Jasinski-Bergner, Kangbo Li, et al.
European Journal of Radiology|January 3, 2019
CT-guided nephrostomy-An expedient tool for complex clinical scenariosMaximilian Peter Brandt, Thomas Lehnert, Theresa Czilwik, et al.
Central European Journal of Urology|June 30, 2026
Digital health engagement among urological patients in four European countries: findings from an international cross-sectional survey by the European Association of Urology Section of Outpatient and Office UrologyJohannes Salem, Juan Jose Menendez-Suarez, Matyas Benyo, et al.
Pageof 13